The Cognitive Neuroscience Journal

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - The Cognitive Neuroscience Journal (2024) Volume 7, Issue 2

Complexities of Post-Traumatic Stress Disorder (PTSD) understanding, diagnosis, and treatment

Marjan Peter*

Department of Medicine, Johns Hopkins University School of Medicine, USA.

*Corresponding Author:
Marjan Peter
Department of Medicine,
Johns Hopkins University School of Medicine,

Received: 25-Mar-2024, Manuscript No. aacnj-24-136340; Editor assigned: 28-Mar-2024, PreQC No. aacnj-24-136340(PQ); Reviewed: 11-Apr-2024, QC No. aacnj-24-136340; Revised: 16-Apr-2024, Manuscript No. aacnj-24-136340(R); Published: 23-Apr-2024, DOI:10.35841/aacnj-7.2.203 .

Citation: Peter M. Complexities of Post-Traumatic Stress Disorder (PTSD) understanding, diagnosis, and treatment. J Cogn Neurosci. 2024;7(2):203.

Visit for more related articles at The Cognitive Neuroscience Journal


Post-Traumatic Stress Disorder (PTSD) is a debilitating psychiatric condition that can develop after exposure to traumatic events. Characterized by a range of distressing symptoms, PTSD profoundly impacts the lives of affected individuals, interfering with their ability to function socially, occupationally, and emotionally. In this comprehensive exploration, we delve into the complexities of PTSD, examining its etiology, clinical presentation, diagnostic criteria, and evidence-based treatments [1].

PTSD can arise following exposure to traumatic events that involve actual or threatened death, serious injury, or sexual violence. Common precipitating events include combat exposure, physical or sexual assault, natural disasters, accidents, and terrorist attacks.

Severity and Nature of Trauma type, intensity, and duration of trauma play a significant role in the development of PTSD. Events that are perceived as life-threatening or involve betrayal, helplessness, or extreme violence are more likely to result in PTSD [2].

Pre-existing factors such as genetic predisposition, early life experiences, personality traits, coping strategies, and previous trauma history can increase susceptibility to PTSD. Social support networks, including family, friends, and community resources, can mitigate the risk of PTSD by providing emotional support, practical assistance, and a sense of belonging.

Individuals with PTSD may experience intrusive memories, flashbacks, nightmares, or distressing thoughts related to the traumatic event. These symptoms can be triggered by reminders or cues associated with the trauma. Avoidance behaviors and emotional numbing are common in PTSD. Affected individuals may avoid reminders of the trauma, including people, places, activities, or conversations that evoke distressing memories or emotions [3].

PTSD can lead to pervasive negative alterations in mood, cognition, and beliefs about oneself, others, or the world. Symptoms may include persistent negative emotions, diminished interest in previously enjoyable activities, feelings of detachment or estrangement, and distorted beliefs about blame, guilt, or worthlessness. Individuals with PTSD may exhibit heightened arousal, vigilance, and reactivity to potential threats. Symptoms may include irritability, anger outbursts, difficulty concentrating, hypervigilance, exaggerated startle response, and sleep disturbances [4].

The diagnosis of PTSD is based on criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which requires the presence of specific symptom clusters and impairment in social, occupational, or other important areas of functioning. To meet criteria for PTSD, an individual must have experienced a qualifying traumatic event and exhibit symptoms from each of the four symptom clusters for a specified duration. The diagnosis of PTSD often requires a comprehensive clinical evaluation, including a detailed history, psychiatric assessment, and assessment of functional impairment [5].

PTSD is a treatable condition, and a variety of evidence-based interventions are available to help individuals recover and reclaim their lives. Psychotherapy, particularly trauma-focused therapies such as Cognitive Processing Therapy (CPT), Prolonged Exposure (PE) therapy, Eye Movement Desensitization and Reprocessing (EMDR) therapy, and Trauma-focused Cognitive Behavioral Therapy (TF-CBT), are highly effective in reducing PTSD symptoms by helping individuals process traumatic memories, challenge maladaptive beliefs, and develop coping skills [6].

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are the first-line pharmacological treatments for PTSD. These medications can help alleviate symptoms of depression, anxiety, and hyperarousal associated with PTSD.

Mindfulness-based interventions, relaxation techniques, yoga, and acupuncture may be beneficial in reducing PTSD symptoms and improving overall well-being by promoting relaxation, stress reduction, and emotional regulation. Peer support groups, self-help resources, and community-based organizations can provide valuable support and validation to individuals with PTSD, fostering a sense of connection, understanding, and empowerment. While significant progress has been made in the understanding and treatment of PTSD, challenges remain in addressing the complex needs of affected individuals and improving access to evidence-based care [7].

Identifying individuals at risk for PTSD and intervening early after trauma exposure can help prevent the development of chronic PTSD and mitigate long-term adverse outcomes.Tailoring treatment approaches to individual needs, preferences, and comorbidities can optimize outcomes and reduce barriers to care for individuals with PTSD [8].

Increasing access to evidence-based treatments, reducing stigma associated with mental health care, and addressing disparities in access to care among underserved populations are essential steps in closing treatment gaps and improving outcomes for individuals with PTSD. Emerging research in neuroscience, genetics, and neuroimaging holds promise for advancing our understanding of the neurobiological underpinnings of PTSD and identifying novel targets for treatment development [9].

Post-Traumatic Stress Disorder (PTSD) is a complex and debilitating psychiatric condition that can profoundly impact the lives of affected individuals. With a comprehensive understanding of its etiology, clinical presentation, diagnosis, and treatment approaches, clinicians and researchers are better equipped to address the needs of individuals with PTSD and promote recovery and resilience. By advancing our knowledge, reducing stigma, and increasing access to evidence-based care, we can strive towards a future where individuals affected by PTSD receive the support and resources they need to heal and thrive [10].


  1. Adamou M, Puchalska S, Plummer W, et al. Valproate in the treatment of PTSD: systematic review and meta analysis. Curr Med Res Opin. 2007;23(6):1285-91.

Indexed at, Google Scholar, Cross Ref

  1. Diagnostic A. Statistical Manual of mental disorders. 1994.

Google Scholar

  1. Baker DG, Diamond BI, Gillette G, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacol. 1995;122:386-9.

Indexed at, Google Scholar, Cross Ref

  1. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders–first revision. World J Biol Psychiatry. 2008;9(4):248-312.

Indexed at, Google Scholar, Cross Ref

  1. Bartzokis G, Lu PH, Turner J, et al. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biological psych. 2005;57(5):474-9.

Indexed at, Google Scholar, Cross Ref

  1. Blake DD, Weathers FW, Nagy LM, et al. The development of a clinician-administered PTSD scale. J traumatic stress. 1995;8:75-90.

Indexed at, Google Scholar, Cross Ref

  1. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283(14):1837-44.

Indexed at, Google Scholar, Cross Ref

  1. Brady KT, Sonne S, Anton RF, et al. Sertraline in the treatment of co?occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005;29(3):395-401.

Indexed at, Google Scholar, Cross Ref

  1. Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry. 1990;51(6):236-8.

Indexed at, Google Scholar

  1. Breslau N, Kessler RC, Chilcoat HD, et al. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998;55(7):626-32.

Indexed at, Google Scholar, Cross Ref

Get the App